Fact CheckerSign in

NCT02310399Recruiting

Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves

Source: ClinicalTrials.gov · Last updated 28 Aug 2026

Brief summary (registry, in English)

This study is a feasibility study of the Nucleus 24 ABI in children without NF2. It will be conducted as a repeated-measures, single subject experiment in order to accommodate the known variability in cochlear implant clinical results. Data obtained in the course of this study will be compared with the existing published outcome data from children with normal hearing and with cochlear implants (CIs). These comparisons may provide additional useful information about the progress of ABI subjects' performance over time. Also, this may allow the results of the current study to be utilized to design future pivotal studies of the device in the pediatric population.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
28 Nov 2014
Start date
May 2014
Primary completion date
May 2030
Lead sponsor
NYU Langone Health
NCT number
NCT02310399

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From May 2014 to the primary completion date, May 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Clear surgical reason for poor CI performance that can be remediated with revision CI or contralateral surgery rather than ABI.
  • Need for brainstem irradiation

Other illness

  • Intractable seizures or progressive, deteriorating neurological disorder
  • Unable to tolerate general anesthesia (cardiac, pulmonary, bleeding diathesis, etc.).

Age

  • Pre- or post-linguistic child currently making significant progress with CI Even for the very young children (18 months of age with 6 months of use), nearly all children with a good auditory signal from their CI will show evidence of improvement in these metrics over time.
  • Unable to participate in behavioral testing and mapping with their CI. If this appears to be an age effect, ABI will be delayed until we can be assured that the child will be able to participate, as reliable objective measures of mapping are currently not available for mapping these devices.

Other

  • For both Groups 1 and 2:
  • MRI evidence of one of the following:
    • normal cochlea and cochlear nerves or NF2
    • brainstem or cortical anomaly that makes implantation unfeasible
  • Patients with evidence of Chiari malformation, hydrocephalus, spina bifid a
  • Patients with any foreseeable need for a future MRI scan
  • Unrealistic expectations on the part of the subject/family regarding the possible benefits, risks and limitations inherent to the procedure and ABI device.
  • Unwilling to sign the informed consent.
  • Unwilling to make necessary follow-up appointments.

Who the study is looking for

  • Group 1: Prelinguistic hearing loss (birth-5 years; age at implantation of ABI 18 months-5 years)
  • Pre-linguistic hearing loss (birth-5 yrs.; age at ABI 18 months-5yrs) with both:
  • MRI +/- CT evidence of one of the following:
    • Cochlear nerve deficiency
    • Cochlear aplasia or severe hypoplasia
    • Severe inner ear malformation
    • Post-meningitis ossification
  • When a cochlea is present or patent, lack of significant benefit from CI despite consistent use (\>6 mo.)
    • No or limited speech perception ability (limited to pattern perception on closed set testing materials using the CI)
    • Lack of progress in auditory skills development
    • Group 2: Post-linguistic hearing loss (\<21 yrs. of age)
  • Post-linguistic hearing loss (\<21 yrs. of age) with:
    • Loss or lack of benefit from appropriate CI without the possibility for revision or contralateral implantation. Examples might include:
    • Post-meningitis ossification
    • Bilateral temporal bone fractures with cochlear nerve avulsion
    • Failed revision CI without benefit
    • Previously developed open set speech perception and auditory-oral language skills
  • No medical contraindications
  • Willing to receive the appropriate meningitis vaccinations
  • No or limited cognitive/developmental delays.
  • Strong family support
  • Reasonable expectations from parents/guardians including a thorough understanding:
    • of potential benefits and limitations of ABI
    • of parental role in rehabilitation
    • that the child may not develop spoken language as a primary communication mode or even sufficient spoken language to make significant academic progress in an aural/oral environment
  • Involvement in a rehabilitation program that emphasizes development of auditory skills with or without the use of supplementary visual communication.
  • Able to comply with study requirements including travel to investigation sites.
  • Informed consent for the procedure from the child's parents/legal guardian.

Age in the registry: 18 months to 21 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NYU Cochlear Implant Center
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.